[1]
Barohn, R.J. et al. 2022. Determining Best or Inferior Drug(s) Using an Adaptive Platform for Cryptogenic Sensory Polyneuropathy. RRNMF Neuromuscular Journal. 3, 2 (Jun. 2022), 45–98. DOI:https://doi.org/10.17161/rrnmf.v3i2.18133.